Explore how resilient supply chains have become a critical component of success for organizations operating in advanced therapies and

For many companies in advanced therapies and medical manufacturing, supply chain disruptions were once viewed primarily as operational inconveniences.

Many emerging cell and gene therapy companies hesitate to enter supply agreements because they believe they are too small,

Selecting the correct inline filter is critical in the cell therapy manufacturing process to ensure product purity and efficacy.